Monitor for any future conversion to a Schedule 13D, which would signal activist intent. For now, the passive filing suggests no immediate change in strategy.
Price Chart
How similar events traded
Executive Summary
Nantahala Capital Management disclosed a passive 8.62% stake in Fulcrum Therapeutics as of September 30, 2026, up from a prior filing where it reported zero shares. The increase is a routine update for a passive investment adviser and does not signal activist intent.
Key Financial Metrics
Key Facts
- Nantahala Capital Management reported beneficial ownership of 6,575,352 shares (8.62%) of Fulcrum Therapeutics as of September 30, 2026.
- The filing is an amendment to Schedule 13G, indicating passive investment intent.
- The stake increased from zero shares in a prior filing to 6,575,352 shares.
- Wilmot B. Harkey and Daniel Mack are also named as reporting persons with the same 8.62% beneficial ownership.
Financial Impact
Stake valued at approximately $24.7M based on $286M market cap and 8.62% ownership.
Risk Factors
- Passive holder could sell shares, creating downward pressure.
- No indication of activist engagement; filing is routine.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-127211 |
| Document: 0001104659-26-127211-index.html | 0001104659-26-127211 |
| Document: 0001104659-26-127211.txt | 0001104659-26-127211 |
Track record
23 reports on FULC
6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +7.71% at T+60 after the Jul 15, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $3.72 Now $3.71 −0.27% settles Nov 18
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $3.73 Now $3.71 −0.40% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $3.77 Now $3.71 −1.59% settles Nov 17
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $3.77 Now $3.71 −1.59% settles Nov 17
- Nov 12, 20264d ago 425 Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $3.77 to $3.71 Now $3.71 −1.59% ▼ −1.59% +0.32% vs SPY
- Nov 5, 202612d ago EFFECT Neutral 4/10 Entry $3.68 to $3.70 Now $3.71 +0.82% ▲ +0.54% +0.23% vs SPY
- Nov 3, 202613d ago S-4/A Neutral 5/10 Entry $3.74 to $3.77 Now $3.71 −0.80% ▲ +0.80% −0.85% vs SPY
- Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $3.75 to $3.77 Now $3.71 −1.07% ▲ +0.53% +0.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers